Today, the U.S. Food and Drug Administration authorized marketing of the first test to aid in newborn screening for Duchenne Muscular Dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness.
from FDA Press Releases RSS Feed https://ift.tt/2PE088d
via IFTTT
No comments:
Post a Comment